Dr. Mulinde is currently the Senior Policy Advisor for the Division of Clinical Compliance Evaluation in the Office of Scientific Investigations, CDER, FDA. Prior to joining the Office of Scientific Investigations, she was a Clinical Team Leader in the Division of Anti-Infective Products in CDER’s Office of New Drugs. She received her M.D. and completed a residency in Internal Medicine at the University of South Alabama School of Medicine, and then completed a fellowship in Infectious Diseases at the University of Maryland School of Medicine. Before joining the FDA, she served as Assistant Professor of Medicine in the Division of Infectious Diseases, Program of Traumatology, at the University of Maryland’s R. Adams Cowley Shock Trauma Center.
Once the venue is selected, the agenda set and speakers are confirmed we’ll keep you posted with a simple email. And to whet your appetite, you’ll receive useful metric-based nuggets of information.